» Articles » PMID: 32848054

Age-related Loss of Neural Stem Cell O-GlcNAc Promotes a Glial Fate Switch Through STAT3 Activation

Overview
Specialty Science
Date 2020 Aug 28
PMID 32848054
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Increased neural stem cell (NSC) quiescence is a major determinant of age-related regenerative decline in the adult hippocampus. However, a coextensive model has been proposed in which division-coupled conversion of NSCs into differentiated astrocytes restrict the stem cell pool with age. Here we report that age-related loss of the posttranslational modification, O-linked β--acetylglucosamine (O-GlcNAc), in NSCs promotes a glial fate switch. We detect an age-dependent decrease in NSC O-GlcNAc levels coincident with decreased neurogenesis and increased gliogenesis in the mature hippocampus. Mimicking an age-related loss of NSC O-GlcNAcylation in young mice reduces neurogenesis, increases astrocyte differentiation, and impairs associated cognitive function. Using RNA-sequencing of primary NSCs following decreased O-GlcNAcylation, we detected changes in the STAT3 signaling pathway indicative of glial differentiation. Moreover, using O-GlcNAc-specific mass spectrometry analysis of the aging hippocampus, together with an in vitro site-directed mutagenesis approach, we identify loss of STAT3 O-GlcNAc at Threonine 717 as a driver of astrocyte differentiation. Our data identify the posttranslational modification, O-GlcNAc, as a key molecular regulator of regenerative decline underlying an age-related NSC fate switch.

Citing Articles

Brain O-GlcNAcylation: Bridging physiological functions, disease mechanisms, and therapeutic applications.

Chen L, Jiang H, Licinio J, Wu H Mol Psychiatry. 2025; .

PMID: 40033044 DOI: 10.1038/s41380-025-02943-z.


Brain Transcriptome Changes Associated With an Acute Increase of Protein O-GlcNAcylation and Implications for Neurodegenerative Disease.

Bell M, Kane M, Ouyang X, Young M, Jegga A, Chatham J J Neurochem. 2025; 169(1):e16302.

PMID: 39823370 PMC: 11741514. DOI: 10.1111/jnc.16302.


Rescuable sleep and synaptogenesis phenotypes in a model of O-GlcNAc transferase intellectual disability.

Czajewski I, Swain B, Xu J, McDowall L, Ferenbach A, van Aalten D Elife. 2024; 13.

PMID: 39535175 PMC: 11623933. DOI: 10.7554/eLife.90376.


A cellular identity crisis? Plasticity changes during aging and rejuvenation.

Gorelov R, Hochedlinger K Genes Dev. 2024; 38(17-20):823-842.

PMID: 39293862 PMC: 11535162. DOI: 10.1101/gad.351728.124.


Navigating the Neuroimmunomodulation Frontier: Pioneering Approaches and Promising Horizons-A Comprehensive Review.

Krsek A, Ostojic L, Zivalj D, Baticic L Int J Mol Sci. 2024; 25(17).

PMID: 39273641 PMC: 11396210. DOI: 10.3390/ijms25179695.


References
1.
Kim S, Maynard J, Sasaki Y, Strickland A, Sherman D, Brophy P . Schwann Cell O-GlcNAc Glycosylation Is Required for Myelin Maintenance and Axon Integrity. J Neurosci. 2016; 36(37):9633-46. PMC: 5039245. DOI: 10.1523/JNEUROSCI.1235-16.2016. View

2.
Love M, Huber W, Anders S . Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15(12):550. PMC: 4302049. DOI: 10.1186/s13059-014-0550-8. View

3.
Smith L, He Y, Park J, Bieri G, Snethlage C, Lin K . β2-microglobulin is a systemic pro-aging factor that impairs cognitive function and neurogenesis. Nat Med. 2015; 21(8):932-7. PMC: 4529371. DOI: 10.1038/nm.3898. View

4.
Wang A, Jensen E, Rexach J, Vinters H, Hsieh-Wilson L . Loss of O-GlcNAc glycosylation in forebrain excitatory neurons induces neurodegeneration. Proc Natl Acad Sci U S A. 2016; 113(52):15120-15125. PMC: 5206508. DOI: 10.1073/pnas.1606899113. View

5.
Choi S, Bylykbashi E, Chatila Z, Lee S, Pulli B, Clemenson G . Combined adult neurogenesis and BDNF mimic exercise effects on cognition in an Alzheimer's mouse model. Science. 2018; 361(6406). PMC: 6149542. DOI: 10.1126/science.aan8821. View